Investor Presentaiton slide image

Investor Presentaiton

6 Driving Long Term Growth by Dual Profits Self-Developed Products ✓ Target difficult-to-make (peptide)API in our portfolio ✓ Tap into drug product related to our API core competencies ✓ Target 505(b)(2) and Paragraph IV drug product via strategic alliances Contract Services ✓ Provide CRO/CMO for APIs ✓ Offer integrated service from API to formulation for niche injectables ✓ Provide biologics fill & finish CMO services ScinoPharm
View entire presentation